Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events
Background It is not known whether drugs that block the renin-angiotensin system reduce the risk of diabetes and cardiovascular events in patients with impaired glucose tolerance. Methods In this double-blind, …
Read more on New England Journal of Medicine
Tareg is a Valsartan formulation that’s not marketed in USA. It’s produced by Novartis pharma to be marketed in Africa, Asia and Middle east. It’s a generic product of the pioneer Diovan. There are 4 concentrations of Tareg 40, 80, 160 and 320mg Valsartan.
Valsartan is a white fine powder that is soluble in alcohol and [...]
Exforge is a new antihypertensive medication produced by Novartis pharma. It combines between two main antihypertensive classes (Angiotensin Receptor Blockers as Valsartan and Calcium channel Blockers as Amlodipine). It’s been prescribed by doctors in case of chronic high blood pressure when one drug is not enough.